1. García-Martín, Elena, Esguevillas, Gara, Serrador, Mercedes, Agúndez, José A G, Jiménez-Jiménez, Félix Javier. 2018. Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine. In Journal of neural transmission (Vienna, Austria : 1996), 125, 689-698. doi:10.1007/s00702-017-1834-4. https://pubmed.ncbi.nlm.nih.gov/29299688/
2. Saha, Sharmistha, Chatterjee, Mahasweta, Sinha, Swagata, Mukhopadhyay, Kanchan. 2021. A pioneering study indicate role of GABRQ rs3810651 in ASD severity of Indo-Caucasoid female probands. In Scientific reports, 11, 7010. doi:10.1038/s41598-021-86496-5. https://pubmed.ncbi.nlm.nih.gov/33772085/
3. Li, Yue-Hui, Liu, Yan, Li, Yan-Dong, Xie, Ping-Li, Li, Guan-Cheng. . GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. In World journal of gastroenterology, 18, 2704-11. doi:10.3748/wjg.v18.i21.2704. https://pubmed.ncbi.nlm.nih.gov/22690081/
4. Lee, Dongjun, Ha, Mihyang, Hong, Chae Mi, Oh, Sae-Ock, Kim, Yun Hak. 2019. GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma. In Oncology letters, 18, 5731-5738. doi:10.3892/ol.2019.10960. https://pubmed.ncbi.nlm.nih.gov/31788046/